Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

66.49
Delayed Data
As of Jul 22
 -1.04 / -1.54%
Today’s Change
50.90
Today|||52-Week Range
127.00
-10.91%
Year-to-Date
Siegfried Holdings, Held by Tweedy Browne, Way Undervalued
Jul 22 / GuruFocus News - Paid Partner Content
Barbarian At The Gate: Mallinckrodt (MNK)
Jul 20 / TheStreet.com - Paid Partner Content
4 Low P/CF Stocks to Improve Your Value Investing
Jul 22 / Zacks.com - Paid Partner Content
Research Reports for Amazon, IBM, Cisco & others
Jul 19 / Zacks.com - Paid Partner Content
Strong On High Volume: Mallinckrodt (MNK)
Jul 21 / TheStreet.com - Paid Partner Content
Looking for Bargain Stocks? Pick These 5 with Low P/B Ratio
Jul 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close67.53
Today’s open67.53
Day’s range65.85 - 68.00
Volume945,199
Average volume (3 months)2,385,243
Market cap$7.3B
Dividend yield--
Data as of 4:02pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+12.32%
Earnings growth (next 5 years)+9.47%
Revenue growth (last year)+31.75%
P/E ratio20.2
Price/Sales2.40
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+0.83+1.69%
VRXValeant Pharmaceutic...-1.66-6.78%
TAROTaro Pharmaceutical ...+0.09+0.06%
SGENSeattle Genetics Inc-0.41-0.92%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$2.00
Annual revenue (last year)$3.3B
Annual profit (last year)$322.1M
Net profit margin9.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts

Partner Offers

Search for Jobs